FORMULATION, DEVELOPMENT AND CHARACTERIZATION OF SOLID LIPID NANOPARTICLES OF GEMCITABINE HYDROCHLORIDE
Journal Title: Journal of Drug Delivery and Therapeutics - Year 2017, Vol 7, Issue 1
Abstract
Gemcitabine Hydrochloride is a BCS class III drug of choice in the treatment of cancer, as a single or in combination chemotherapy. However, its bioavailability is a major concern due to its short half-life. Solid lipid nanoparticles (SLN) of Gemcitabine Hydrochloride were prepared to enhance its bioavailability, hence anticancer activity. The Quality by Design approach was applied for the formulation of SLN. The Randomized 32 factorial design was used with responses of particle size and % entrapment efficiency (% EE). The optimized batch of Gemcitabine Hydrochloride loaded SLN containing 1gm of GMS as solid lipid, 1gm of Tween80: Sodium Taurocholate as surfactant:co-surfactant and 5mg of Gemcitabine Hydrochloride was prepared by high shear homogenization method followed by Probe sonication for 15min to form nanoparticulate SLN dispersion. The Optimized batch of Gemcitabine Hydrochloride loaded SLN that exhausted mean particle size of 126.1nm, zeta potential -28.6 mV and % EE 74.83% respectively. SEM studies revealed three-dimensional nature of SLN with a slightly rough surface. DSC, results exhibited entrapment of Gemcitabine Hydrochloride in SLN. The optimized batch of SLN was evaluated for in-vitro % drug release using cellulose membrane dialysis bags for 24hrs and showed 63.13% CDR at 24 hrs. Anticancer cell line studies were also performed in human lung cancer cell line (A-549). It concludes that Gemcitabine Hydrochloride loaded Solid lipid Nanoparticles was successfully formulated and evaluated to sustain the drug release by bypassing the first pass metabolism.
Authors and Affiliations
Shahanoor Momin
Keywords
Related Articles
- EP ID EP294077
- DOI 10.22270/jddt.v7i1.1349
- Views 101
- Downloads 0
DEVELOPMENT AND OPTIMIZATION OF CHRONOPHARMACEUTICAL DRUG DELIVERY SYSTEM FOR ASTHMA
The present research was designed to increase bioavailability and solubility of Montulokast Sodium by formulating Chrono pharmaceutical delivery system. In the present study firstly immediate release core tablets were pr...
SYNTHESIS OF ZNO NANOGEL FOR THE TREATMENT OF SUPERFICIAL SKIN MICROBIAL INFECTIONS
Zinc oxide (ZnO) nanogel is an antimicrobial gel comprising of ZnO nanoparticles. Since, in nanoparticles, the surface to volume ratio is very large, therefore, ZnO nanogel is more effective for the treatment of superfic...
STABILITY TESTING GUIDELINES OF PHARMACEUTICAL PRODUCTS
Stability studies of pharmaceutical products ensuring the maintenance of product quality, safety and efficacy throughout the shelf life are considered as pre-requisite for the acceptance and approval of any pharmaceutica...
FUNDAMENTAL ASPECTS IN THE DEVELOPMENT OF MICROEMULSION SYSTEMS CONTAINING AMPHOTERICIN B FOR OPHTHALMIC USE
This is an overview of the development of microemulsion systems containing amphotericin B for ophthalmic use. The amphotericin B (AmB) is used to treat a fungal infection of eye and bioavailability of the AmB is the chal...
UNDERSTANDING THE MECHANISM OF DRUG-RESISTANT AND TUMOR RECURRENCE IN LIVER CANCER
Chemo-resistant and tumor recurrence are the major hurdle to overcome the cancer patients. Especially in hepatocellular carcinoma (HCC) is notoriously refractory to chemotherapy because of its tendency to develop multi-d...